LY3009120, a panRAF Inhibitor, Has Significant Anti-Tumor Activity in BRAF and KRAS Mutant Preclinical Models of Colorectal Cancer
Oncotarget - United States
doi 10.18632/oncotarget.14002
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 16, 2016
Authors
Publisher
Impact Journals, LLC